Mexico’s negotiations of important free trade agreements (FTAs) have triggered national and international discussions on the role of IP rights in trade. The discussion of IP rights chapters has scaled up to the point that they have been considered breaking points in all negotiations.
IP discussions have challenges in three main areas: internet use of IP rights, geographical indications and appellations of origin, and patents and their interplay with the regulatory processes for drugs.
In the regulatory process the topics of discussion in general have been: